According to World Health Organization definition:
Pharmacovigilance: is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine related problem.
We are committed to provide quality products that meet the requirements of our patients at all times and ensure their safety through the effective implementation of a rigorous pharmacovigilance system.
Our Pharmacovigilance Department manages a pharmacovigilance system for the collection, collation, and evaluation of adverse events and the implementation of effective corrective and preventive actions.
For medical information enquiries, complaints and adverse events reporting
Jordan:
+962 (6) 4023072, Ext.: 353
+962796684957
Qppv@ammanpharma.com
KSA:
+966507917875
966(11)4646955, Ext.: 847
Ghadah.Alotaibi@ammanpharma.com
To report any safety or quality issue please contact us using the following contact details of the Pharmacovigilance department:
**Please note that Reporter’s and patient’s identity are held in strict confidence and protected to the fullest extent of the law, information provided by the reporter will be strictly protected and will not be used in any way against him.
Amman Pharmaceutical Industries (API) was established in 1989 as one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of Ophthalmology, ENT (Ear, Nose & Throat ) , respiratory, and Dermatology. After many years of success.
